Mrs. Hanna M Boles, RN Registered Nurse - Community Health Medicare: Not Enrolled in Medicare Practice Location: 115 Guffey St, Celina, TN 38551 Phone: 931-243-2651 Fax: 931-243-3132 |
Mandy N Hayes, FNP-C Registered Nurse Medicare: Medicare Enrolled Practice Location: 102 Old Jefferson St, Celina, TN 38551 Phone: 931-243-3576 |
Anitra Ostos, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 115 Guffey St, Celina, TN 38551 Phone: 931-243-2651 |
Timothy Tiernan, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 115 Guffey St, Tenn Department Of Health, Celina, TN 38551 Phone: 931-243-2651 |
Mrs. April Beth Collins, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 115 Guffey St, Celina, TN 38551 Phone: 931-243-3153 Fax: 931-243-3132 |
Amanda Naff, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 115 Guffey St, Celina, TN 38551 Phone: 931-243-2651 |
News Archive
RainDance Technologies, Inc., a private company pioneering microdroplet-based technologies for single molecule and single cell analysis, today announced that the company has been recognized by the Museum of Science, Boston and the Boston Patent Law Association for its innovations and contributions to advancing the field of genetic research.
A highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to accurately determine whether patients with HPV-related oropharyngeal squamous cell carcinoma are free from cancer following radiation therapy.
The question of whether the term ‘fat' is more appropriate than ‘obese' was raised in an Australian study that confirmed the former is the "lesser of two evils". The study from University of NSW study which looked at public perceptions surrounding these words has found that, while both are unwelcome, obese was viewed more negatively.
Gilead Sciences, Inc. today announced that its head-to-head Phase III clinical trial of Cayston (aztreonam for inhalation solution) versus tobramycin inhalation solution in cystic fibrosis patients with Pseudomonas aeruginosa achieved one of its co-primary endpoints of non-inferiority for mean percent change in forced expiratory volume in one second (FEV1) percent predicted after 28 days of treatment.
› Verified 9 days ago